ErbB2-mediated tumorigenesis involves [2,6] activation of receptor tyrosine kinases [5,7], induction of cyclin D1/CDK activity [8], and functional restraint by tumor suppressors [9,10,11]. Here, ERBB2 is linked to neoplasm.